These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15124551)

  • 1. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
    Peiffert D
    Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience].
    Touboul E; Moureau-Zabotto L; Lerouge D; Pène F; Deniaud-Alexandre E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Schlienger M; Laugier A
    Cancer Radiother; 2003 Nov; 7 Suppl 1():91s-99s. PubMed ID: 15124550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
    Matzinger O; Roelofsen F; Mineur L; Koswig S; Van Der Steen-Banasik EM; Van Houtte P; Haustermans K; Radosevic-Jelic L; Mueller RP; Maingon P; Collette L; Bosset JF;
    Eur J Cancer; 2009 Nov; 45(16):2782-91. PubMed ID: 19643599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer of the anal canal].
    Ruíz Molina JM; Gómez Aceytuno R; Gallardo Rincón D; Herrera R; Mondragón Sánchez RJ; Oñate Ocaña LF; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1997; 62(3):184-8. PubMed ID: 9480525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC).
    Takashima A; Shimada Y; Hamaguchi T; Ito Y; Nakano A; Nakamura K; Shibata T; Fukuda H; Moriya Y;
    Jpn J Clin Oncol; 2011 May; 41(5):713-7. PubMed ID: 21467080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
    Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
    Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of carcinoma anal canal with combination chemotherapy and concurrent radiotherapy.
    Mishra RC; Senapati S; Sai PL
    J Indian Med Assoc; 1996 Feb; 94(2):53-4, 57. PubMed ID: 8810177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
    Windschall A; Ott OJ; Sauer R; Strnad V
    Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.
    Peiffert D; Giovannini M; Ducreux M; Michel P; François E; Lemanski C; Mirabel X; Cvitkovic F; Luporsi E; Conroy T; Gérard JP;
    Ann Oncol; 2001 Mar; 12(3):397-404. PubMed ID: 11332154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of 44 patients with anal canal carcinoma. Argentinian Intergroup for the treatment of gastrointestinal tumors (IATTGI)].
    Roca E; Milano MC; Pennella E; Barugel M; Gualdrini U; Lumi M; Gonzalez G; Sardi M; Fleischer I; Graziano A
    Medicina (B Aires); 1995; 55(3):243-8. PubMed ID: 8544723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.
    Olivatto LO; Cabral V; Rosa A; Bezerra M; Santarem E; Fassizoli A; Castro L; Simões JH; Small IA; Ferreira CG
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):490-5. PubMed ID: 20472349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.